Connect
← Return to video from PCRI suggests long-term beam radiation BCR rates are 50%
Discussion
video from PCRI suggests long-term beam radiation BCR rates are 50%
Prostate Cancer | Last Active: 1 day ago | Replies (49)Comment receiving replies
@brianjarvis
My involvement with UFHPTI is not a clinical trial. I had 30 rounds of proton radiation prescribed to me by the R/O after their physics deapartment makes their reocmmendations.
The study I am in is looking at the success, side affects, issues, problems of proton and photon radiation treatments. Not many currect long term studies being done. The study is to look at those who have already gone through treatments.
I hope I did not infer I was in clinical trial. It is an after treatment study.
Replies to "@brianjarvis My involvement with UFHPTI is not a clinical trial. I had 30 rounds of proton..."
Connect
@jc76 There are two clinical trials looking into this; COMPPARE and PARTIQoL.
—> The PARTIQoL trial interim results are showing that both therapies achieved similar tumor control rates and patient-reported quality of life outcomes. Specifically, there was no significant difference in progression-free survival or patient-reported outcomes like urinary, bowel, and sexual function
—> The COMPPARE trial is another large-scale study also comparing proton therapy and IMRT, but with a different focus on patient-reported outcomes. The COMPPARE trial is still ongoing.
The COMPPARE and PartiQoL trials seem to be showing no different QoL or success rate outcomes between proton and photon radiation. If so, does this spell the end of proton radiation for prostate cancer, as instance companies will lean towards the much less expensive photon?